/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that iNtRON has demonstrated the effectiveness of P18-BE3CRC using a.
/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that it has completed the efficacy evaluation study of BAL200, a novel.
/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that the Company has established the 2nd generation technology of.